OREANDA-NEWS. October 28, 2014. The Federal Antimonopoly Service (FAS Russia) held TEVA PHARMACEUTICAL INDUSTRIES LIMITED (Israel) administratively liable for failure to execute a determination and fined the company 300,000 RUB.

In December 2013, the antimonopoly authority found that TEVA violated Clause 5 Part 1 Article 10 of the Federal Law “On Protection of Competition” by refusing to conclude a contract with “BIOTEK” MFPDK” CJSC for supplying “Copaxone” without economic and technological justification and issued a determination aimed at supporting competition.

In January 2014, “BIOTEK” MFPDK”CJSC asked TEVA twice to conclude a contract for supplying “Copaxone”; however, TEVA refused to enter into the contract.

Thus, TEVA failed to execute the FAS determination.

“Failure to execute a determination of the antimonopoly body constitutes a violation of the antimonopoly law and is punishable by administrative sanctions. Legitimacy of the determination issued to TEVA is confirmed by the ruling of the 9th Arbitration Appeal Court of 23 September 2014”, pointed out the Head of FAS Department for Control over Social Sphere and Trade, Timophei Nizhegorodtsev.